- Home
- RELY vs PTCT Comparison
RELY vs PTCT Comparison
Compare RELY & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELY
- PTCT
- Stock Information
- Founded
- RELY 2011
- PTCT 1998
- Country
- RELY United States
- PTCT United States
- Employees
- RELY N/A
- PTCT N/A
- Industry
- RELY Computer Software: Prepackaged Software
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- RELY Technology
- PTCT Health Care
- Exchange
- RELY Nasdaq
- PTCT Nasdaq
- Market Cap
- RELY 4.6B
- PTCT 3.9B
- IPO Year
- RELY 2021
- PTCT 2013
- Fundamental
- Price
- RELY $17.02
- PTCT $47.66
- Analyst Decision
- RELY Buy
- PTCT Buy
- Analyst Count
- RELY 10
- PTCT 14
- Target Price
- RELY $27.40
- PTCT $63.57
- AVG Volume (30 Days)
- RELY 3.6M
- PTCT 1.1M
- Earning Date
- RELY 07-30-2025
- PTCT 08-07-2025
- Dividend Yield
- RELY N/A
- PTCT N/A
- EPS Growth
- RELY N/A
- PTCT N/A
- EPS
- RELY N/A
- PTCT 7.51
- Revenue
- RELY $1,356,469,000.00
- PTCT $1,772,758,000.00
- Revenue This Year
- RELY $27.85
- PTCT $121.37
- Revenue Next Year
- RELY $20.30
- PTCT N/A
- P/E Ratio
- RELY N/A
- PTCT $6.34
- Revenue Growth
- RELY 34.37
- PTCT 91.12
- 52 Week Low
- RELY $12.43
- PTCT $29.02
- 52 Week High
- RELY $27.32
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- RELY 27.22
- PTCT 46.87
- Support Level
- RELY $17.07
- PTCT $47.28
- Resistance Level
- RELY $17.75
- PTCT $49.45
- Average True Range (ATR)
- RELY 0.58
- PTCT 1.48
- MACD
- RELY -0.07
- PTCT -0.12
- Stochastic Oscillator
- RELY 5.78
- PTCT 31.91
About RELY Remitly Global Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.